menu
    • menu

    Company profile for Cocrystal Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis C viruses, influenza viruses, noroviruses and coronaviruses. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, bro...
    Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis C viruses, influenza viruses, noroviruses and coronaviruses. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cocrystal PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19805 N. Creek Parkway Bothell, WA 98011
    Telephone
    Telephone
    877-COCP123
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cocrystalpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cocrystal-pharma-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cocrystalpharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cocrystal Pharma to Present at 21st Emerging Growth Conference
    Cocrystal Pharma to Present at 21st Emerging Growth Conference

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196941/0/en/Cocrystal-Pharma-to-Present-at-the-Noble-Capital-Markets-21st-Emerging-Growth-Equity-Conference.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Cocrystal Pharma Reveals Q3 2025 Financials & Pipeline Updates
    Cocrystal Pharma Reveals Q3 2025 Financials & Pipeline Updates

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188274/0/en/Cocrystal-Pharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Updates-on-its-Antiviral-Drug-Development-Programs.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Cocrystal Pharma Insiders Buy $1.03M In Nasdaq at-The-Market
    Cocrystal Pharma Insiders Buy $1.03M In Nasdaq at-The-Market

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177339/0/en/Cocrystal-Pharma-Insiders-Purchase-1-03-Million-in-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Cocrystal Pharma Secures NIH SBIR Award For Advancing Influenza
    Cocrystal Pharma Secures NIH SBIR Award For Advancing Influenza

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174513/0/en/Cocrystal-Pharma-Receives-NIH-SBIR-Award-to-Advance-its-Influenza-Inhibitor-Program.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Cocrystal Pharma To Present At Noble Capital Markets Conference
    Cocrystal Pharma To Present At Noble Capital Markets Conference

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160321/0/en/Cocrystal-Pharma-to-Present-at-Noble-Capital-Markets-Emerging-Growth-Virtual-Equity-Conference.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Cocrystal Pharma Closes $13M Direct Offering Under Nasdaq Rules
    Cocrystal Pharma Closes $13M Direct Offering Under Nasdaq Rules

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3150405/0/en/Cocrystal-Pharma-Inc-Announces-Closing-of-Up-To-13-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search